To Development and Validation RP-HPLC Method for Tinidazole in Bulk and Pharmaceutical Formulation.

Fuente: Zenodo
Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Asha Chopde*, Babu Anmulwad, Vanita Mehetre, Pooja Sakharkar
Format: Recurso digital
Veröffentlicht: Zenodo 2025
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1866902232342986752
author Asha Chopde*, Babu Anmulwad, Vanita Mehetre, Pooja Sakharkar
author_facet Asha Chopde*, Babu Anmulwad, Vanita Mehetre, Pooja Sakharkar
contents <p><span lang="EN">A simple, precise, accurate, and robust Reverse Phase High-Performance Liquid Chromatography (RP-HPLC) method was developed and validated for the quantitative estimation of Tinidazole in bulk and pharmaceutical dosage forms. Chromatographic separation was achieved using a mobile phase of Acetonitrile and Water (90:10 v/v), with the detection wavelength set at 270 nm. The method demonstrated excellent linearity in the concentration range of 5–30 µg/ml, with a correlation coefficient (r²) of 0.9996. The Limit of Detection (LOD) and Limit of Quantitation (LOQ) were found to be 2.5070 µg/ml and 7.5912 µg/ml respectively. Validation parameters such as system suitability, specificity, accuracy, precision (intra-day and inter-day), robustness, and sensitivity were conducted in accordance with ICH guidelines, confirming the reliability and reproducibility of the method. Recovery studies showed results within the acceptable range, indicating no interference from excipients. The proposed method is suitable for routine analysis of Tinidazole in both bulk drug and pharmaceutical formulations due to its simplicity, sensitivity, and cost-effectiveness.</span></p>
format Recurso digital
id zenodo_https___doi_org_10_5281_zenodo_16359467
institution Zenodo
language
publishDate 2025
publisher Zenodo
record_format zenodo
spellingShingle To Development and Validation RP-HPLC Method for Tinidazole in Bulk and Pharmaceutical Formulation.
Asha Chopde*, Babu Anmulwad, Vanita Mehetre, Pooja Sakharkar
Tinidazole, RP-HPLC, Method Development, Validation, Pharmaceutical Formulation, Accuracy, Precision, Linearity, ICH Guidelines, Analytical Method.
<p><span lang="EN">A simple, precise, accurate, and robust Reverse Phase High-Performance Liquid Chromatography (RP-HPLC) method was developed and validated for the quantitative estimation of Tinidazole in bulk and pharmaceutical dosage forms. Chromatographic separation was achieved using a mobile phase of Acetonitrile and Water (90:10 v/v), with the detection wavelength set at 270 nm. The method demonstrated excellent linearity in the concentration range of 5–30 µg/ml, with a correlation coefficient (r²) of 0.9996. The Limit of Detection (LOD) and Limit of Quantitation (LOQ) were found to be 2.5070 µg/ml and 7.5912 µg/ml respectively. Validation parameters such as system suitability, specificity, accuracy, precision (intra-day and inter-day), robustness, and sensitivity were conducted in accordance with ICH guidelines, confirming the reliability and reproducibility of the method. Recovery studies showed results within the acceptable range, indicating no interference from excipients. The proposed method is suitable for routine analysis of Tinidazole in both bulk drug and pharmaceutical formulations due to its simplicity, sensitivity, and cost-effectiveness.</span></p>
title To Development and Validation RP-HPLC Method for Tinidazole in Bulk and Pharmaceutical Formulation.
topic Tinidazole, RP-HPLC, Method Development, Validation, Pharmaceutical Formulation, Accuracy, Precision, Linearity, ICH Guidelines, Analytical Method.
url https://doi.org/10.5281/zenodo.16359467